{
    "clinical_study": {
        "@rank": "111108", 
        "arm_group": [
            {
                "arm_group_label": "Grupo 0", 
                "description": "Null or mild fibrosis"
            }, 
            {
                "arm_group_label": "Grupo 1", 
                "description": "Cirrhosis"
            }, 
            {
                "arm_group_label": "Grupo 2", 
                "description": "HCC diagnosis"
            }
        ], 
        "biospec_descr": {
            "textblock": "Serum, plasma, white cells"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The aim of this study is to establish a clinical score panel based on clinical, molecular\n      and genetic parameters that allow us to stratify and obtain an early detection of patients\n      with an increased risk of developing hepatocellular carcinoma (HCC)."
        }, 
        "brief_title": "Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acquired Immunodeficiency Syndrome Virus", 
            "Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted", 
            "Hepatocellular Carcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Acquired Immunodeficiency Syndrome", 
                "HIV Infections", 
                "Carcinoma", 
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis C", 
                "Immunologic Deficiency Syndromes", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "detailed_description": {
            "textblock": "Transversal study design like a \"proof of concept\".\n\n      Primary objective:\n\n      The main objective is try to stablish a descriptive panel (first phase of a score system)\n      based in the conjunction or sum of several clinical and laboratory parameters (molecular and\n      genetic factors). The aim is to detect in a fast, early and successful way those patients\n      that presents a high risk to develop an hepatocellular carcinoma (HCC) in the future in a\n      specific population: HIV and HCV coinfected patients. The establishment of this panel will\n      allow clinicians set up a correct treatment decreasing the probability of liver cirrhosis\n      and HCC."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Human immunodeficiency virus chronic infection\n\n          -  Hepatitis C virus chronic infection\n\n          -  No other liver viral coinfections\n\n        Exclusion Criteria:\n\n          -  Alcohol consume\n\n          -  Immunosuppressor or immunoactive treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "HIV/HCV coinfected patients from Infectious Diseases Department"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02113865", 
            "org_study_id": "FMM115392013"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 14, 2014", 
        "location": {
            "contact": {
                "email": "itziar.pablo@salud.madrid.org", 
                "last_name": "Itziar de Pablo"
            }, 
            "contact_backup": {
                "email": "bsastre@salud.madrid.org", 
                "last_name": "Beatriz Sastre"
            }, 
            "facility": {
                "address": {
                    "city": "Madrid", 
                    "country": "Spain"
                }, 
                "name": "Hospital Ram\u00f3n y Cajal"
            }, 
            "investigator": {
                "last_name": "Beatriz Sastre, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "3", 
        "official_title": "Obtenci\u00f3n de un Panel de puntuaci\u00f3n (\"Score System\") Para la predicci\u00f3n de Riesgo Individualizado y la detecci\u00f3n Precoz de Carcinoma Hepatocelular (HCC) en Sujetos Coinfectados VIH/VHC", 
        "other_outcome": {
            "description": "Genetic polymorphisms will be evaluated using Real-Time polymerase chain reaction technique", 
            "measure": "Evaluation of genetic polymorphisms distribution between study groups of relevant genes probably implicated in the disease", 
            "safety_issue": "No", 
            "time_frame": "1 day (Routine visit in normal following at Infectious Disease Department)"
        }, 
        "overall_official": {
            "affiliation": "Fundaci\u00f3n para la Investigaci\u00f3n Biom\u00e9dica del Hospital Ram\u00f3n y Cajal", 
            "last_name": "Beatriz S Sastre, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Inflammatory markers will be measure used a Enzyme-linked Immunosorbent Assay", 
            "measure": "Sera inflammatory markers", 
            "safety_issue": "No", 
            "time_frame": "1 day (Routine visit to normal following in Infectious Disease Department)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02113865"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Apoptotic markers will be evaluated through a Enzyme-linked Immunosorbent Assay", 
            "measure": "Sera apoptotic markers", 
            "safety_issue": "No", 
            "time_frame": "1 day (Routine visit in disease following at Infectious Disease Department)"
        }, 
        "source": "Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal", 
        "sponsors": {
            "collaborator": {
                "agency": "Fundaci\u00f3n Mutua Madrile\u00f1a", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}